The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Ray Debanjan since year 2005.
The trader's CIK number is 1706863.
At the time of this reporting, Ray Debanjan is the Chief Financial Officer of Cytomx Therapeutics, Inc. .
(stock ticker symbol CTMX).
See this page for all insider trading activities at Cytomx Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-02||CTMX||Cytomx Therapeutics, Inc.||Sale||2,500||21.11||52,775|
|2017-12-01||CTMX||Cytomx Therapeutics, Inc.||Sale||2,500||20.58||51,449|
|2017-11-01||CTMX||Cytomx Therapeutics, Inc.||Sale||2,500||20.00||50,000|
|2017-10-02||CTMX||Cytomx Therapeutics, Inc.||Sale||2,500||18.10||45,250|
|2017-09-01||CTMX||Cytomx Therapeutics, Inc.||Sale||2,500||17.17||42,925|
|2017-08-09||CTMX||Cytomx Therapeutics, Inc.||Sale||2,500||15.00||37,500|
|2017-07-03||CTMX||Cytomx Therapeutics, Inc.||Sale||2,500||15.47||38,675|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ray Debanjan (Chief Financial Officer of Cytomx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.